Short-Term, Combined Fasting and Exercise Improves Body Composition in Healthy Males.


Journal

International journal of sport nutrition and exercise metabolism
ISSN: 1543-2742
Titre abrégé: Int J Sport Nutr Exerc Metab
Pays: United States
ID NLM: 100939812

Informations de publication

Date de publication:
01 Nov 2020
Historique:
received: 10 03 2020
revised: 21 07 2020
accepted: 22 07 2020
pubmed: 1 10 2020
medline: 20 1 2021
entrez: 30 9 2020
Statut: epublish

Résumé

Fasting enhances the beneficial metabolic outcomes of exercise; however, it is unknown whether body composition is favorably modified on the short term. A baseline-follow-up study was carried out to assess the effect of an established protocol involving short-term combined exercise with fasting on body composition. One hundred seven recreationally exercising males underwent a 10-day intervention across 15 fitness centers in the Netherlands involving a 3-day gradual decrease of food intake, a 3-day period with extremely low caloric intake, and a gradual 4-day increase to initial caloric intake, with daily 30-min submaximal cycling. Using dual-energy X-ray absorptiometry analysis, all subjects substantially lost total body mass (-3.9 ± 1.9 kg; p < .001) and fat mass (-3.3 ± 1.3 kg; p < .001). Average lean mass was lost (-0.6 ± 1.5 kg; p < .001), but lean mass as a percentage of total body mass was not reduced. The authors observed a loss of -3.9 ± 1.9% android fat over total fat mass (p < .001), a loss of -2.2 ± 1.9% gynoid over total fat mass (p < .001), and reduced android/gynoid ratios (-0.05 ± 0.1; p < .001). Analyzing 15 preselected single-nucleotide polymorphisms in 13 metabolism-related genes revealed trending associations for thyroid state-related single-nucleotide polymorphisms rs225014 (deiodinase 2) and rs35767 (insulin-like growth factor1), and rs1053049 (PPARD). In conclusion, a short period of combined fasting and exercise leads to a substantial loss of body and fat mass without a loss of lean mass as a percentage of total mass.

Identifiants

pubmed: 32998111
doi: 10.1123/ijsnem.2020-0058
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

386-395

Commentaires et corrections

Type : ErratumIn

Auteurs

Giuseppe Delli Paoli (G)

Università degli Studi della Campania "Luigi Vanvitelli".
European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).

Denise van de Laarschot (D)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
Erasmus University Medical Center.

Edith C H Friesema (ECH)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
Erasmus University Medical Center.

Remco Verkaik (R)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
European Nutraceutical Services.

Antonia Giacco (A)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
Università degli Studi del Sannio.

Rosalba Senese (R)

Università degli Studi della Campania "Luigi Vanvitelli".
European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).

Pascal P Arp (PP)

Erasmus University Medical Center.

P Mila Jhamai (PM)

Erasmus University Medical Center.

Stefano M Pagnotta (SM)

Università degli Studi del Sannio.

Linda Broer (L)

Erasmus University Medical Center.

André G Uitterlinden (AG)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
Erasmus University Medical Center.

Antonia Lanni (A)

Università degli Studi della Campania "Luigi Vanvitelli".
European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).

M Carola Zillikens (MC)

European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).
Erasmus University Medical Center.

Pieter de Lange (P)

Università degli Studi della Campania "Luigi Vanvitelli".
European Consortium for Lifestyle, Exercise, Adaptation, and Nutrition (EULEAN).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH